Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Dendritic Cell Vaccination in Metastatic Renal Cell Carcinoma
NCT00197860Phase 2Completed
- Start
- Sep 2004
- Primary completion
- Dec 2009
- Modality
- Prophylactic Vaccines, Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of autologous dendritic cell vaccine in renal cell carcinoma (RCC). Started Sep 2004; status: completed.
02
Drugs
autologous dendritic cell vaccine
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00197860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00197860.